My Fund Comparison
Initilizing list...
|
Tekla World Healthcare Fund as of
03/27/2023
| NYSE /
THW |
Asset Class:
Sector Equity Funds
|
1 YR Lipper Avg:
-10.65% |
| Growth of $10K |
|
| Avg Annual Total Return % |
| |
10 YR |
5 YR |
1 YR |
YTD |
| Market Return |
-- |
12.10% |
-0.12% |
-5.99% |
| Lipper Pct. Rank |
-- |
7 |
5 |
91 |
|
| NAV Return |
-- |
8.24% |
-6.23% |
-2.70% |
| Lipper Pct. Rank |
-- |
40 |
50 |
77 |
| Premium/Discount History |
|
| Premium/Discount |
| 10 YR Avg |
5 YR Avg |
YTD Avg |
|
-- |
0.581% |
11.660% |
|
| NAV |
$12.42 |
Market Price |
$13.40 |
| Net Change |
$0.07 |
Market Change |
-$0.06 |
| Premium/Discount |
7.89% |
| 1 YR NAV Return |
-6.227% |
| 1 YR NAV Rank |
50 |
| 12-Mo Yield as of
2/28/2023 |
Yield
Def |
| Income Only Yield |
0.37% |
| Distribution Yield (Market) |
10.00% |
| Most Recent Income Dividend |
$0.117 |
| Ex-Div Date |
2/17/2023 |
| Most Recent Cap Gain Dividend |
$0.117 |
| Ex-Div Date |
12/19/2019 |
| Dividend Frequency |
Monthly |
| YTD Dividends |
$0.233 |
| YTD Capital Gains |
-- |
| Inception Date |
6/30/2015 |
| Fund Advisor |
Tekla Capital Management LLC |
| Manager & Tenure |
Team Managed |
| Phone |
800-426-5523 |
| Website |
www.teklacap.com |
| Total Net Assets (mil)
as of
2/28/2023 |
$468.6 |
| % Leveraged Assets
as of
9/30/2022 |
18.91% |
| Portfolio Turnover |
44.00% |
| Mgmt Fees |
1.233% |
| Expense Ratio |
1.910% |
| Fund Objective |
| The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities, convertible securities and debt securities. |
|
| Top Holdings
(as of 9/30/2022) |
|
Johnson & Johnson ORD |
6.94% |
|
UnitedHealth Group Inc ORD |
6.61% |
|
ROCHE HOLDINGS ADR |
5.40% |
|
Abbott Laboratories ORD |
4.58% |
|
ASTRAZENECA ADR REP 0.5 ORD |
4.58% |
|
Eli Lilly and Co ORD |
4.07% |
|
Pfizer Inc ORD |
3.63% |
|
Abbvie Inc ORD |
3.29% |
|
NOVO NORDISK ADR REPSG 1 ORD |
2.86% |
|
Merck & Co Inc ORD |
2.84% |
|
| Top Sectors
(as of 9/30/2022) |
|
Health Care |
95.33% |
|
Financials |
4.86% |
|
Non Classified Equity |
2.29% |
|
Industrials |
1.68% |
|
Consumer Services |
1.30% |
|
Technology |
0.84% |
|
|
Resources
abrdn CEF Investor Center
Asset TV — CEF Channel
CEF Connect
Cohen & Steers CEFs Knowledge Center
Harvest — CEFA Channel
Franklin Templeton CEFs
Seeking Alpha — CEFA Channel
|
|
Powered by a SySys® data & content management system.
© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|